1. Home
  2. SSB vs KYMR Comparison

SSB vs KYMR Comparison

Compare SSB & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SouthState Corporation

SSB

SouthState Corporation

N/A

Current Price

$102.72

Market Cap

9.9B

Sector

Finance

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$121.03

Market Cap

9.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSB
KYMR
Founded
1933
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
9.0B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
SSB
KYMR
Price
$102.72
$121.03
Analyst Decision
Buy
Strong Buy
Analyst Count
14
24
Target Price
$119.64
★ $145.22
AVG Volume (30 Days)
718.2K
★ 912.7K
Earning Date
10-21-2026
10-29-2026
Dividend Yield
★ 2.56%
N/A
EPS Growth
★ 12.91
N/A
EPS
★ 6.93
N/A
Revenue
N/A
★ $39,211,000.00
Revenue This Year
$1.59
$153.48
Revenue Next Year
$7.06
N/A
P/E Ratio
$14.87
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$85.51
$63.69
52 Week High
$112.20
$142.92

Technical Indicators

Market Signals
Indicator
SSB
KYMR
Relative Strength Index (RSI) 43.21 47.18
Support Level $100.33 $104.96
Resistance Level $104.34 $128.95
Average True Range (ATR) 2.10 7.47
MACD -0.38 -1.35
Stochastic Oscillator 3.01 14.51

Price Performance

Historical Comparison
SSB
KYMR

About SSB SouthState Corporation

SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: